Skip to content
Screener

Mirion Technologies MIR Medical — D&A

Other segment segments

Nuclear & Safety
$22.9M+32.4%

Similar metrics at other companies

Becton, Dickinson and Company logo
BDXMedical — D&A
$348.25M+14.6%
Becton, Dickinson and Company logo
BDXMedical Essentials — D&A
$147M+8.1%
Novanta logo
NOVTMedical Solutions — D&A
$8.61M-11.7%
Johnson & Johnson logo
JNJMedical Devices — D&A
$864M+2.6%
Healthcare Realty Trust logo
HRMedial Outpatient Properties Segment — D&A
$128.99M-17.3%
Signet Jewelers logo
SIGInternational segment — D&A
$2.3M-4.2%

Other financials

Income statement

See full
Revenue$266.8M+19.7%
Gross profit$133.1M+29.9%
Operating income$17.9M+80.8%
Net income$7.7M-7.2%
EPS (diluted)$0.030.0%

Balance sheet

See full
Cash & equivalents$421.6M+60.3%
Total debt$476.6M-0.1%
Total equity$1.8B+24.9%
Total assets$3.5B+28.6%

Cash flow

See full
Operating cash flow$58.5M+372%
CapEx$10.4M+18.2%
Free cash flow$48.1M+1,236%

Valuation

See full
Market cap$3.74B-24.7%
Enterprise value$3.8B-26.7%
P/E152.7×
P/S3.7×-2.0×

Profitability

See full
Gross margin48%+1.3pp
Operating margin5.3%+0.1pp
Net margin2.4%
FCF margin13%+3.6pp

Returns & leverage

See full
Return on equity1.5%
Debt / equity0.3×-0.1×
Current ratio3.2×+0.7×

Where this comes from

Reported directly by Mirion Technologies in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The source filing: Mirion Technologies’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-050604
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Corporate and other1.50.82.21.2
Total capital expenditures$11.7$9.4$20.9$18.0
Depreciation and amortization
Nuclear & Safety$22.9$17.3$47.2$34.2
Medical15.616.331.832.7
Total operating and reportable segments38.533.679.066.9
Corporate and other0.30.30.60.6
Total depreciation and amortization$38.8$33.9$79.6$67.5

Item 1. Financial Statements (Unaudited)

FAQ

What is Mirion Technologies's medical — D&A?
Mirion Technologies (MIR) reported medical — D&A of $15.6M in Q2 2026.
How has Mirion Technologies's medical — D&A changed year-over-year?
Mirion Technologies's medical — D&A decreased by 4.3% year-over-year, from $16.3M to $15.6M.
What is the long-term trend for Mirion Technologies's medical — D&A?
Over 3 years (2022 to 2025), Mirion Technologies's medical — D&A has grown at a -7.4% compound annual growth rate (CAGR), from $82.4M to $65.5M.
What does medical — D&A mean?
Represents the systematic allocation of the cost of tangible and intangible assets over their useful lives within the Medical segment. This non-cash expense reflects the wear and tear of equipment and the consumption of acquired intangible assets like patents or customer relationships. It is a critical component for understanding the segment's asset intensity and for reconciling operating income to cash flow.

Ask your AI about Mirion Technologies's medical — d&a.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude